CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Net revenue	$ 805,975	$ 793,286	$ 1,598,472	$ 1,537,912
Revenue, Product and Service [Extensible Enumeration]			Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
Costs and expenses:
Cost of net revenue	678,973	673,397	$ 1,354,666	$ 1,328,793
Cost, Product and Service [Extensible Enumeration]			Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
General and administrative expenses	57,012	50,078	$ 105,390	$ 97,599
Depreciation and amortization, excluding patient equipment depreciation	11,395	15,549	22,760	31,081
Goodwill impairment (note 5)	6,548	0	13,078	0
Total costs and expenses	753,928	739,024	1,495,894	1,457,473
Operating income	52,047	54,262	102,578	80,439
Interest expense, net	33,038	32,552	65,510	64,507
Change in fair value of warrant liability (note 10)	(7,010)	(812)	443	(22,726)
Other (income) loss, net	(1,760)	2,082	3,345	3,257
Income before income taxes	27,779	20,440	33,280	35,401
Income tax expense	7,248	5,399	13,858	3,685
Net income	20,531	15,041	19,422	31,716
Income attributable to noncontrolling interest	1,096	1,064	2,121	2,032
Net income attributable to AdaptHealth Corp.	$ 19,435	$ 13,977	$ 17,301	$ 29,684
Weighted average common shares outstanding - basic (in shares)	133,218	134,295	133,066	134,409
Weighted average common shares outstanding - diluted (in shares)	136,029	136,233	135,698	138,000
Basic net income per share (note 11) (in dollars per share)	$ 0.13	$ 0.10	$ 0.12	$ 0.20
Diluted net income per share (note 11) (in dollars per share)	$ 0.13	$ 0.09	$ 0.12	$ 0.03